Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0U0CV
|
|||
| Former ID |
DNC014029
|
|||
| Drug Name |
Dodecane-1-sulfonyl fluoride
|
|||
| Synonyms |
dodecane-1-sulfonyl fluoride; Dodecanesulfonyl fluoride; CHEMBL97038; dodecyl sulfonyl fluoride; 1-(Fluorosulfonyl)dodecane; SCHEMBL1470419; BDBM50132715
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H25FO2S
|
|||
| Canonical SMILES |
CCCCCCCCCCCCS(=O)(=O)F
|
|||
| InChI |
1S/C12H25FO2S/c1-2-3-4-5-6-7-8-9-10-11-12-16(13,14)15/h2-12H2,1H3
|
|||
| InChIKey |
UVLRFDMRDPQRSM-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cannabinoid receptor 1 (CB1) | Target Info | Inhibitor | [1] |
| Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] | |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Rap1 signaling pathway | ||||
| Neuroactive ligand-receptor interaction | ||||
| Panther Pathway | Anandamide degradation | |||
| Endogenous cannabinoid signaling | ||||
| Pathway Interaction Database | N-cadherin signaling events | |||
| Reactome | Class A/1 (Rhodopsin-like receptors) | |||
| G alpha (i) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Small Ligand GPCRs | ||||
| BDNF signaling pathway | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| GPCRs, Other | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Monoacylglycerol lipase regulates 2-arachidonoylglycerol action and arachidonic acid levels. Bioorg Med Chem Lett. 2008 Nov 15;18(22):5875-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.